Get the Stockscreener App
84.09
2.24%
-1.93
After Hours:
84.09
Edwards Lifesciences Corp stock is traded at $84.09, with a volume of 3.57M.
It is down -2.24% in the last 24 hours and up +11.69% over the past month.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
See More
Previous Close:
$86.02
Open:
$86.02
24h Volume:
3.57M
Relative Volume:
0.80
Market Cap:
$49.37B
Revenue:
$5.88B
Net Income/Loss:
$1.34B
P/E Ratio:
35.80
EPS:
2.3489
Net Cash Flow:
$799.60M
1W Performance:
-2.35%
1M Performance:
+11.69%
6M Performance:
+8.04%
1Y Performance:
+20.92%
1-Day Range:
$84.02
$86.86
1-Week Range:
$83.32
$86.86
52-Week Range:
$65.94
$87.20
Edwards Lifesciences Corp Stock (EW) Company Profile
Name
Edwards Lifesciences Corp
Sector
Industry
Phone
(949) 250-2500
Address
ONE EDWARDS WAY, IRVINE, CA
Compare EW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
84.09 | 49.92B | 5.88B | 1.34B | 799.60M | 2.3489 |
|
ABT
Abbott Laboratories
|
123.97 | 219.36B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.60 | 143.81B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
360.48 | 139.29B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.35 | 128.70B | 34.76B | 4.79B | 5.30B | 3.7049 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-29-25 | Upgrade | Jefferies | Hold → Buy |
| Oct-29-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Oct-08-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-29-25 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-24-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-30-25 | Upgrade | Stifel | Hold → Buy |
| Jan-16-25 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Dec-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-11-24 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-18-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-24 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jul-29-24 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jul-25-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-25-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-25-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-25-24 | Downgrade | TD Cowen | Buy → Hold |
| Jul-25-24 | Downgrade | Truist | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| May-14-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-07-24 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Nov-28-23 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Sep-26-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-08-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-06-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-31-23 | Downgrade | Bernstein | Outperform → Underperform |
| Jan-30-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-06-22 | Downgrade | Stifel | Buy → Hold |
| Oct-28-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-26-22 | Initiated | Mizuho | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-29-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-27-22 | Reiterated | Citigroup | Buy |
| Jan-27-22 | Reiterated | Evercore ISI | Outperform |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | Stifel | Buy |
| Jan-27-22 | Reiterated | UBS | Neutral |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Dec-06-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-30-21 | Reiterated | Canaccord Genuity | Buy |
| Jul-30-21 | Reiterated | Deutsche Bank | Hold |
| Jul-30-21 | Reiterated | Jefferies | Buy |
| Jul-30-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-30-21 | Reiterated | Oppenheimer | Outperform |
| Jul-30-21 | Reiterated | Stifel | Buy |
| Jul-30-21 | Reiterated | UBS | Neutral |
| Jul-30-21 | Reiterated | Wells Fargo | Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Apr-05-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-11-20 | Reiterated | Canaccord Genuity | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Underperform |
| Apr-28-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-17-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-10-20 | Initiated | Oppenheimer | Outperform |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-24-19 | Reiterated | Canaccord Genuity | Buy |
| Sep-23-19 | Initiated | Piper Jaffray | Overweight |
| Jul-24-19 | Reiterated | BofA/Merrill | Buy |
| Mar-18-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Hold |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-16-18 | Initiated | Barclays | Underweight |
| Oct-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-02-18 | Downgrade | Guggenheim | Buy → Neutral |
View All
Edwards Lifesciences Corp Stock (EW) Latest News
Vanguard Group Inc. Grows Position in Edwards Lifesciences Corporation $EW - MarketBeat
Will Edwards Lifesciences Corporation (EWL) stock rise with strong economyJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com
Primecap Management Co. CA Acquires 1,147,291 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Highview Capital Management LLC DE Cuts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Stock Holdings Cut by Intech Investment Management LLC - MarketBeat
Why Edwards Lifesciences Corporation stock remains a top recommendationJuly 2025 Outlook & Daily Momentum Trading Reports - newser.com
Tick level data insight on Edwards Lifesciences Corporation volatilityTrade Entry Report & Risk Adjusted Swing Trade Ideas - newser.com
Is Edwards Lifesciences Corporation (EWL) stock a top dividend aristocrat candidateQuarterly Profit Report & AI Forecasted Entry and Exit Points - newser.com
Why Edwards Lifesciences Corporation stock attracts HNW investors2025 Risk Factors & Safe Capital Allocation Plans - newser.com
Is Edwards Lifesciences Corporation (EWL) stock positioned for secular growthMarket Trend Review & Free Daily Entry Point Trade Alerts - newser.com
What is the fair value estimate for Edwards Lifesciences Corporation (EWL) stock in 2025Market Rally & Weekly High Return Opportunities - newser.com
Can Edwards Lifesciences Corporation (EWL) stock sustain free cash flowPortfolio Update Report & Growth Oriented Trade Recommendations - newser.com
Why Edwards Lifesciences Corporation (EWL) stock stays on top picksPortfolio Risk Summary & Short-Term Swing Trade Alerts - newser.com
Philips, Edwards team on AI-based guide for mitral valve repair - MedTech Dive
What does recent volatility data suggest for Edwards Lifesciences CorporationPortfolio Return Report & Safe Entry Zone Identification - newser.com
Edwards Lifesciences stock rating reiterated at Overweight by Piper Sandler - Investing.com India
How Edwards Lifesciences Corporation stock trades after rate cutsJobs Report & AI Forecast Swing Trade Picks - newser.com
Edwards Lifesciences Corporation $EW Shares Sold by Thoroughbred Financial Services LLC - MarketBeat
Edwards Lifesciences Corporation $EW Shares Acquired by Citigroup Inc. - MarketBeat
What consensus target says about Edwards Lifesciences Corporation stockMarket Sentiment Report & AI Forecast Swing Trade Picks - newser.com
Is Edwards Lifesciences Corporation (EWL) stock a safe buy pre earnings - newser.com
Published on: 2025-11-17 10:29:32 - newser.com
Why Edwards Lifesciences Corporation (EWL) stock stays resilient2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
Ontario Teachers Pension Plan Board Raises Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Is Edwards Lifesciences Corporation stock trading at attractive multiplesPortfolio Value Report & Risk Controlled Daily Trade Plans - newser.com
Edwards Lifesciences’ PROGRESS Trial: A Game-Changer in Aortic Stenosis Treatment? - MSN
Edwards Lifesciences’s SWOT analysis: strong TAVR growth drives stock outlook - Investing.com
Published on: 2025-11-17 11:56:48 - newser.com
Edwards Lifesciences Corporation $EW Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $11.25 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Creative Planning Buys 15,336 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation stock trend forecastPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com
WealthShield Partners LLC Buys New Position in Edwards Lifesciences Corporation $EW - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Boosts Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Empower Advisory Group LLC Has $74.29 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Buys Shares of 48,589 Edwards Lifesciences Corporation $EW - MarketBeat
Using data models to predict Edwards Lifesciences Corporation stock movement2025 Momentum Check & Fast Gain Stock Tips - newser.com
Will Edwards Lifesciences Corporation (EWL) stock test record highs in 2025Wall Street Watch & Capital Efficient Trade Techniques - newser.com
Oak Harvest Investment Services Makes New $2.24 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Impax Asset Management Group plc Acquires 5,106 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
PNC Financial Services Group Inc. Sells 14,592 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Geode Capital Management LLC Buys 45,555 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp Stock (EW) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.37%
1.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):